Showing results (11-20 of 121) with videos related to
Sort By:
Pageof 13
NPJ Vaccines|May 14, 2021
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2Ian McDonald, Sam M Murray, Catherine J Reynolds, et al.Nature Reviews. Immunology|July 11, 2023
The immunology of long COVIDDaniel M Altmann, Emily M Whettlock, Siyi Liu, et al.Journal of Neuroinflammation|May 13, 2015
Autoantigen cross-reactive environmental antigen can trigger multiple sclerosis-like diseaseCatherine J Reynolds, Malcolm J W Sim, Kathryn J Quigley, et al.Current Opinion in Pulmonary Medicine|April 9, 2005
Infectious lung complications in patients with HIV/AIDSRosemary J BoytonTransactions of the Royal Society of Tropical Medicine and Hygiene|October 25, 2020
Multiplexed gene expression analysis of HLA class II-associated podoconiosis implicates chronic immune activation in its pathogenesisDiana R Alcantara, Christopher I Jones, Daniel M Altmann, et al.European Journal of Immunology|October 16, 2015
KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cellsMalcolm J W Sim, Janet Stowell, Ruhena Sergeant, et al.International Immunology|July 20, 2005
Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spreadRosemary J Boyton, Selina Davies, Chloe Marden, et al.Proceedings of the National Academy of Sciences of the United States of America|May 30, 2019
Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-CMalcolm J W Sim, Sumati Rajagopalan, Daniel M Altmann, et al.Acta Neuropathologica|August 13, 2013
Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell responseDaniel E Lowther, Deborah L Chong, Stephanie Ascough, et al.Journal for Immunotherapy of Cancer|November 8, 2019
Antibiotic therapy and outcome from immune-checkpoint inhibitorsDavid J Pinato, Daria Gramenitskaya, Daniel M Altmann, et al.Pageof 13